Literature DB >> 25592430

Chronic unpredictable mild stress decreases BDNF and NGF levels and Na(+),K(+)-ATPase activity in the hippocampus and prefrontal cortex of mice: antidepressant effect of chrysin.

C B Filho1, C R Jesse2, F Donato1, R Giacomeli1, L Del Fabbro1, M da Silva Antunes1, M G de Gomes1, A T R Goes1, S P Boeira1, M Prigol1, L C Souza1.   

Abstract

Our working hypothesis is that brain neurotrophins and brain Na(+),K(+)-ATPase may be strongly associated with the occurrence of depression in animals subjected to chronic unpredictable mild stress (CUMS). Still, we believe that chrysin, a natural and bioactive flavonoid found in honey and some plants, can provide satisfactory effects on antidepressant therapy. Thus, we aimed to evaluate the effect of CUMS on brain-derived neurotropic factor (BDNF) and nerve growth factor (NGF) levels as well as the Na(+),K(+)-ATPase activity in the hippocampus and prefrontal cortex of female mice. We also aimed to examine the effect of a 28-day oral treatment with chrysin (5 or 20mg/kg) in female mice subjected to CUMS, comparing to the effect of fluoxetine. Results showed that CUMS applied for 28days induced a decrease in BDNF and NGF levels as well as in the Na(+),K(+)-ATPase activity. CUMS also promoted a depressive status in the swimming forced test (FST), in the sucrose preference test, and in corticosterone levels. Chrysin (20mg/kg) and fluoxetine also occasioned the up-regulation of BDNF and NGF levels in non-stressed mice and in mice subjected to CUMS. CUMS decreased non-protein thiol (NPSH) levels and increased reactive oxygen species (ROS) levels. In response to these changes, the glutathione reductase (GR), glutathione peroxidase (GPx) and catalase (CAT) activities were increased in mice exposed to CUMS. Chrysin and fluoxetine treatments protected against all these alterations, suggesting the involvement of the antioxidant function in the antidepressant effect of chrysin and fluoxetine. In conclusion, CUMS decreased BDNF and NGF levels as well as the Na(+),K(+)-ATPase activity in mice. Chrysin presented antidepressant effect in mice on behavioral, neurotrophic and biochemistry parameters equivalent to fluoxetine. Furthermore, we suggest that the up-regulation of BDNF and NGF levels is a mechanism possibly involved in the antidepressant effect of chrysin in mice.
Copyright © 2015 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  chronic stress; corticosterone; depression; flavonoid; oxidative stress

Mesh:

Substances:

Year:  2015        PMID: 25592430     DOI: 10.1016/j.neuroscience.2014.12.048

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  41 in total

1.  A Load to Find Clinically Useful Biomarkers for Depression.

Authors:  Matea Nikolac Perkovic; Marina Sagud; Lucija Tudor; Marcela Konjevod; Dubravka Svob Strac; Nela Pivac
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Unfolding the Role of BDNF as a Biomarker for Treatment of Depression.

Authors:  Tarapati Rana; Tapan Behl; Aayush Sehgal; Pranay Srivastava; Simona Bungau
Journal:  J Mol Neurosci       Date:  2020-11-23       Impact factor: 3.444

3.  LPS-induced impairment of Na+/K+-ATPase activity: ameliorative effect of tannic acid in mice.

Authors:  Karina Pereira Luduvico; Luiza Spohr; Mayara Sandrielly Soares de Aguiar; Fernanda Cardoso Teixeira; Natália Pontes Bona; Julia Eisenhardt de Mello; Roselia Maria Spanevello; Francieli Moro Stefanello
Journal:  Metab Brain Dis       Date:  2022-06-27       Impact factor: 3.655

4.  Involvement of glutamatergic neurotransmission in the antidepressant-like effect of zinc in the chronic unpredictable stress model of depression.

Authors:  Luana M Manosso; Morgana Moretti; André R Colla; Camille M Ribeiro; Tharine Dal-Cim; Carla I Tasca; Ana Lúcia S Rodrigues
Journal:  J Neural Transm (Vienna)       Date:  2016-01-08       Impact factor: 3.575

5.  Normal glutathione levels in autopsied brain of chronic users of heroin and of cocaine.

Authors:  Junchao Tong; Paul S Fitzmaurice; Anna Moszczynska; Gausiha Rathitharan; Lee-Cyn Ang; Jeffrey H Meyer; Romina Mizrahi; Isabelle Boileau; Yoshiaki Furukawa; Tina McCluskey; Napapon Sailasuta; Stephen J Kish
Journal:  Drug Alcohol Depend       Date:  2018-06-23       Impact factor: 4.492

6.  Cardiac glycosaminoglycans and structural alterations during chronic stress-induced depression-like behavior in mice.

Authors:  Hien Luong; Sarojini Singh; Mallikarjun Patil; Prasanna Krishnamurthy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-04-09       Impact factor: 4.733

Review 7.  Natural Compounds as Medical Strategies in the Prevention and Treatment of Psychiatric Disorders Seen in Neurological Diseases.

Authors:  Esra Küpeli Akkol; Irem Tatlı Çankaya; Gökçe Şeker Karatoprak; Elif Carpar; Eduardo Sobarzo-Sánchez; Raffaele Capasso
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

8.  The selective 5-HT1A receptor biased agonists, F15599 and F13714, show antidepressant-like properties after a single administration in the mouse model of unpredictable chronic mild stress.

Authors:  Monika Głuch-Lutwin; Kinga Sałaciak; Alicja Gawalska; Marek Jamrozik; Joanna Sniecikowska; Adrian Newman-Tancredi; Marcin Kołaczkowski; Karolina Pytka
Journal:  Psychopharmacology (Berl)       Date:  2021-05-10       Impact factor: 4.530

9.  Relaxation Response in Stressed Volunteers: Psychometric Tests and Neurotrophin Changes in Biological Fluids.

Authors:  Miriam Zappella; Filippo Biamonte; Bijorn Omar Balzamino; Rocco Manieri; Magdalena Cortes; Daniela Santucci; Enrico Di Stasio; Maurizio Rizzuto; Alessandra Micera
Journal:  Front Psychiatry       Date:  2021-06-17       Impact factor: 4.157

10.  Expression of Selected Genes Involved in Neurogenesis in the Etiopathogenesis of Depressive Disorders.

Authors:  Katarzyna Bliźniewska-Kowalska; Piotr Gałecki; Janusz Szemraj; Monika Talarowska
Journal:  J Pers Med       Date:  2021-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.